VMD
Viemed Healthcare, Inc.
Price as of Jul 20, 2026
VMD overview
Viemed Healthcare, Inc.
Viemed Healthcare, Inc. operates in the Healthcare sector. Its latest one-year return is +87.2%.
Valuation
- P/E forward
- 48.50x
- EV / EBITDA
- 8.85x
- Market cap
- $464.8M
Momentum
- 1 day
- -0.2%
- YTD
- +63.5%
- RSI (14d)
- 67.8
Summary
Viemed Healthcare, Inc. (NASDAQ:VMD) is a Lafayette, Louisiana-based healthcare company founded in 2006 that provides in-home durable medical equipment and post-acute respiratory healthcare services. The company went public in August 2019 and has grown through both organic expansion and strategic acquisitions to become a significant player in the home respiratory care market. Viemed serves patients across all 50 states, focusing primarily on chronic obstructive pulmonary disease (COPD) management, sleep apnea treatment, and related respiratory therapies delivered directly to patients' homes.
Over the past few years, Viemed has executed a comprehensive transformation from a primarily ventilator-focused company to a diversified respiratory healthcare provider. The company successfully restructured its sales organization in 2024, temporarily slowing hiring to train new managers and optimize territories, before resuming aggressive expansion in 2025. Strategic acquisitions have been central to Viemed's growth strategy. The company acquired HMP in 2023, which immediately contributed to revenue growth and expanded geographic reach. In early 2024, Viemed acquired East Alabama HomeMed, establishing a successful joint venture model. Most recently, the company signed an agreement to acquire Lehan's Medical Equipment for $26 million, expanding its presence in Northern Illinois and Chicago while adding capabilities in women's health services. Technology development has accelerated significantly, with the launch of the proprietary Engage Care Manager platform for provider communication and patient monitoring. The company is beta testing machine learning tools to optimize patient care and operational efficiency. These technology investments support Viemed's strategy of providing high-touch, high-technology care that differentiates it from commodity DME providers. Business diversification has reduced dependence on the core ventilation segment from 77% of revenue in 2021 to approximately 55% currently. The sleep business has shown particularly strong growth, increasing 46% year-over-year, while the staffing division has expanded into behavioral health services. The company has also enhanced its oxygen therapy and resupply services, creating multiple revenue streams from each patient relationship.
Profitability
- Gross margin
- 57.3%
- EBIT margin
- 8.4%
- Net margin
- 5.2%
- ROE
- 10.4%
Growth
- Revenue YoY
- +23.1%
- EPS YoY
- +21.9%
- Revenue fwd
- -39.4%
- Revenue CAGR 3y
- +24.9%
Earnings
- Latest EPS
- $0.06
- EPS estimate
- $0.09
- EPS surprise
- -33.3%
- Next EPS est.
- $0.12
Capital & dividend
- Debt / equity
- 0.09x
- Current ratio
- 1.22x
- Dividend yield
- —
- Interest cover
- 18.36x
Financials snapshot
- Revenue · 2025
- $270.3M
- Net income
- $14.9M
- Operating cash flow
- $51.9M
Next expected earnings · 2026-08-05T00:00:00.000Z
Latest news
Stonegate Capital Partners Updates Coverage on Viemed Healthcare, Inc. (VMD) 1Q26
Newsfile Corp · 5/12/2026
Viemed Healthcare Announces First Quarter 2026 Financial Results
ACCESSWIRE · 5/5/2026